Related Experiment Video

Updated: Mar 19, 2026

Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts
09:43

Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts

Published on: August 1, 2025

955

Emerging roles of ATF3 in the suppression of prostate cancer

Ziyan Wang1, Chunhong Yan2

  • 1GRU Cancer Center.

Molecular & Cellular Oncology
|June 17, 2016
PubMed

Insights

Activating transcription factor 3 (ATF3) acts as a tumor suppressor in prostate cancer, particularly in cases with PTEN dysfunction. This finding provides genetic evidence for ATF3's role in suppressing tumor growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Activating transcription factor 3 (ATF3) is a stress response mediator involved in oncogenic pathways, including androgen receptor signaling crucial for prostate cancer cell proliferation.
  • Downregulation of ATF3 expression is frequently observed in human prostate cancers, suggesting a potential role in tumorigenesis.

Purpose of the Study:

  • To investigate the role of ATF3 as a tumor suppressor in prostate cancer.
  • To provide genetic evidence for ATF3's function in a specific subset of prostate cancers characterized by PTEN dysfunction.

Main Methods:

  • Utilizing genetic models to assess the impact of ATF3 on prostate cancer development.
  • Analyzing ATF3 expression patterns in human prostate cancer samples.

Main Results:

  • Demonstrated the first genetic evidence supporting ATF3's function as a tumor suppressor in prostate cancer.
  • Identified a specific subset of prostate cancers with PTEN dysfunction where ATF3 acts as a tumor suppressor.

Conclusions:

  • ATF3 plays a critical role in suppressing prostate tumor formation, especially in the context of PTEN loss.
  • Targeting ATF3 or understanding its pathway may offer new therapeutic strategies for specific prostate cancer subtypes.
Keywords:
ATF3PTENaktprostate cancer

More Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

14.1K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

14.0K

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
65
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K